Isolated and Borderline Isolated Systolic Hypertension Relative to Long-Term Risk and Type of Stroke

Size: px
Start display at page:

Download "Isolated and Borderline Isolated Systolic Hypertension Relative to Long-Term Risk and Type of Stroke"

Transcription

1 Isolated and Borderline Isolated Systolic Hypertension Relative to Long-Term Risk and Type of Stroke A 20-Year Follow-Up of the National Health and Nutrition Survey Adnan I. Qureshi, MD; M. Fareed K. Suri, MD; Yousef Mohammad, MD; Lee R. Guterman, PhD, MD; L. Nelson Hopkins, MD Background and Purpose Although the short-term risks of stroke and types of stroke associated with isolated systolic hypertension (ISH) and borderline isolated systolic hypertension (BISH) have been described, the long-term effects of these hypertensive conditions, particularly in younger individuals, are unclear. We performed this study to evaluate the long-term risks of stroke, type of stroke, and predictors of stroke associated with ISH and BISH and how this risk compares with that for persons with diastolic hypertension and normotension. Methods We used the 20-year follow-up data for adults aged 25 to 74 years who participated in the First National Health and Nutrition Examination Survey Follow-Up Study to determine the aforementioned risks. Blood pressure (BP) measurements of the participants were obtained during baseline evaluation. ISH was defined as systolic BP 160 mm Hg and diastolic BP 90 mm Hg. BISH was defined as systolic BP between 140 and 159 mm Hg and diastolic BP 90 mm Hg. Diastolic hypertension was defined as a diastolic BP 90 mm Hg. Normotension was defined as systolic BP 140 mm Hg and diastolic BP 90 mm Hg. Incidence of stroke overall and incidence of ischemic stroke and intracerebral hemorrhage were determined from a review of hospital records and death certificates. Relative risk (RR) of stroke and stroke type in association with each hypertensive category was determined by Cox proportional hazards analysis after adjustment for potential confounding variables. Results Among the participants, hypertension was categorized as ISH (n 493), BISH (n 1241), and diastolic hypertension (n 3954). Normotension was observed in 6656 persons. After adjustment for differences in age, sex, education, serum cholesterol level, body mass index, diabetes mellitus, and cigarette smoking, a significantly higher RR for all strokes was observed in participants with ISH (RR, 2.7; 95% CI, 2.0 to 3.4) and BISH (RR, 1.4; 95% CI, 1.1 to 1.8) than those with normotension. The risk was significantly higher for ischemic stroke or intracerebral hemorrhage in persons with ISH and BISH. Among the 1734 persons with either ISH or BISH, the risk of stroke was independently associated with older age, diabetes mellitus, and systolic BP 180 mm Hg. Conclusions Increased risks for stroke, ischemic stroke, and intracerebral hemorrhage were observed in patients with BISH, similar to those associated with ISH and diastolic hypertension. Future clinical trials are required to evaluate the effect of antihypertensive treatment in younger patients with BISH and ISH. (Stroke. 2002;33: ) Key Words: hypertension intracerebral hemorrhage stroke stroke, ischemic Acommon belief among patients and some practitioners is that elevated diastolic pressure is more important than elevated systolic pressure. However, recent evidence suggests the importance of systolic blood pressure in determining the risks of myocardial infarction and stroke. 1 3 Two important categories of systolic hypertension have been recognized, which include isolated systolic hypertension (ISH) and borderline isolated systolic hypertension (BISH). ISH is characterized by reduced vascular compliance, often in combination with increased peripheral resistance. In absolute terms, ISH is defined as an elevated systolic blood pressure 160 mm Hg and a normal diastolic blood pressure ( 90 mm Hg). 2,3 BISH was introduced as a category of hypertension by the Joint National Committee in and further emphasized in and in reports on detection, evaluation, and treatment of high blood pressure. The entity was further stressed in the World Health Organization guidelines. 7 BISH is defined as systolic blood pressure between 140 and 159 mm Hg and normal diastolic blood pressure ( 90 mm Hg). 4 The prevalence of systolic hypertension varies, depending on the population screened. In the Hypertension Detection and Follow-Up Program, 8 blood pressures Received April 1, 2002; final revision received June 24, 2002; accepted July 10, From the Department of Neurosurgery, State University of New York at Buffalo (A.I.Q., M.F.K.S., L.R.G., L.N.H.), and Department of Neurology, Ohio State University, Columbus (Y.M.M.). Reprint requests to Adnan I. Qureshi, MD, Department of Neurosurgery, State University of New York at Buffalo, 3 Gates Circle, Buffalo, NY aiqureshi@hotmail.com 2002 American Heart Association, Inc. Stroke is available at DOI: /01.STR F 2781

2 2782 Stroke December 2002 were measured in individuals from 14 communities throughout the United States during The measurements were obtained at the homes of these individuals. Of the total population screened, 2.4% had ISH (systolic blood pressure 160 mm Hg and diastolic blood pressure 90 mm Hg). ISH was present for 0.5% of those aged 30 to 39 years and 6.8% of those aged 60 to 69 years. The prevalence of ISH was greater in blacks and women than in both whites and men. The prevalence of ISH was 5.3% in white men, 6.4% in black men, 7.4% in white women, and 8.3% in black women. In an analysis of 30-year follow-up data from the Framingham Study, Wilking et al 9 reported that ISH occurred in 14% of men and 23% of women aged 65 years and accounted for 57% of all hypertensive conditions in men and 65% in women. Although the risk of stroke overall and according to type and subtype has been evaluated in some clinical trials involving participants with ISH, the long-term natural history of ISH and BISH has not been determined, particularly in younger age groups. We used 20-year follow-up data from the first National Health and Nutrition Examination Survey (NHANES I) Epidemiological Follow-Up Study (NHEFS) to determine the risks of stroke and types of stroke that are associated with ISH and BISH. For a comparative analysis, we estimated the risk of these outcomes in patients with diastolic hypertension and normotension. We also evaluated the factors that increase the risk of stroke in patients with these hypertensive conditions. Subjects and Methods NHANES I was conducted by the National Center for Health Statistics of the Centers for Disease Control and Prevention during to collect health-related information on a probability sample of the civilian, noninstitutionalized population in the United States A sample of approximately persons aged between 1 and 74 years was included. The NHANES I was designed so that certain population groups considered at high risk of malnutrition (such as the elderly, those living in poverty areas, and women of child-bearing age) were oversampled at preset rates. Adjusted sampling weights were computed within 60 age/sex/race categories to inflate the sample to closely reflect the US civilian noninstitutionalized population at the midpoint of the survey. A subset of NHANES I participants who were between the ages of 25 and 74 years (at the time of the baseline survey) received a more detailed health examination. The NHEFS comprised a series of studies to provide follow-up data on these NHANES I participants. The NHEFS included 4 periods of follow-up: , 1986, 1987, and The first wave of data collection was performed during It included tracing the cohort; conducting personal interviews with subject or proxy; measuring pulse rate, weight, and blood pressure of surviving participants; collecting hospital and nursing home records of overnight stay; and collecting death certificates of decedents. Subsequent follow-up of the NHEFS was conducted with the same design and data collection procedures except that a 30-minute computer-assisted telephone interview was administered in place of a personal interview and no physical measurements were made. Tracing and data collection in the NHEFS were very high, with 94% of the study population traced for each completed wave of follow-up. The interview rates ranged from 91% to 96% of the participants traced. By the end of the 1992 NHEFS survey period, 90% of the subjects not reported dead in previous surveys had been successfully traced. 15 Approximately 32% of the NHEFS cohort was known to be deceased, with a death certificate available for 98% of the 4604 NHEFS decedents. An analysis was performed to determine the effect of age at baseline evaluation on loss to follow-up. Age at baseline was categorized into five 10-year age groups. Rates of loss to follow-up were highest for participants aged 45 years (14%) and decreased for subsequent age categories (5% and 6% for participants aged 45 to 64 years and 65 years, respectively). Definitions of Stroke Events and Stroke Types Participants were considered to have experienced a stroke event if they were hospitalized or died during the 20-year follow-up period with primary diagnoses categorized by codes 431 to or 437 to according to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Our definition of stroke event included both ischemic and hemorrhagic events but not transient ischemic events (ICD-9-CM code 435). ICD-9-CM codes were assigned on the basis of the underlying cause of death listed on the participant s death certificate. Stroke events were further classified as intracerebral hemorrhage in participants with ICD-9-CM codes 431 to or as cerebral infarction in those with codes 433 to or 436 to Definitions of Hypertensive Conditions Blood pressure status was categorized on the basis of measurements obtained at physical examination during the NHANES I baseline clinical evaluation. One blood pressure measurement was obtained from all participants in a sitting position and was used for the present analysis. ISH was defined as systolic blood pressure 160 mm Hg and diastolic blood pressure 90 mm Hg. BISH was defined as systolic blood pressure 140 mm Hg and 160 mm Hg and diastolic blood pressure 90 mm Hg. Diastolic hypertension was defined as diastolic blood pressure 90 mm Hg. Normotension was defined as systolic blood pressure 140 mm Hg and diastolic blood pressure 90 mm Hg. A subset of persons (n 6844) evaluated in the NHANES I baseline survey had 3 consecutive blood pressure measurements performed. We determined the correlation between single blood pressure recordings with the average of 3 consecutive blood pressure recordings. Pearson product-moment coefficient was used to test this correlation with the use of JMP statistical software (SAS Institute Inc). A high correlation coefficient of 0.95 and 0.92 for systolic and diastolic blood pressure, respectively, was observed between single recording and average of multiple recordings. Study Variables Known cerebrovascular risk factors that were identified as potential confounding variables in our study of the association between hypertensive conditions and stroke events were age, sex, race/ ethnicity (black, white, other), educational attainment ( 12 years, 12 years), serum cholesterol level ( 200 mg/dl, 200 mg/dl), body mass index (calculated as weight in kilograms divided by the square of the height in meters), diabetes mellitus, and cigarette smoking (never, former, and current). All measurements were obtained prospectively during the NHANES I baseline interview. Information regarding the status of cigarette smoking was obtained from the 1982 follow-up. Socioeconomic data and smoking status were self-reported. Diabetes mellitus was determined from the patient s report of a physician s diagnosis. Trained examiners measured the height and weight of each participant during the NHANES I physical examination. Statistical Analyses Because the duration of follow-up varied among the participants, Cox proportional hazard analysis was used to estimate the relative risk (RR) for stroke and stroke types. We included all patients in the analysis and censored the data for patients who died from noncardiovascular deaths at the time of death. RR for stroke and stroke types for each type of hypertension was estimated after adjustment for the established cerebrovascular risk factors. The Cox proportional hazard model was adjusted for differences in age, sex, race/ethnicity, education, cigarette smoking, serum cholesterol level, diabetes mellitus, history of myocardial infarction, and body mass index. In the present model age was dichotomized at 60 or 60 years. The cutoff for dichotomization is based on the age definitions

3 Qureshi et al ISH and BISH and Stroke Risk 2783 TABLE 1. Baseline Characteristics of Participants According to Blood Pressure Status Characteristics Diastolic Hypertension (n 3954) Isolated Systolic Hypertension (n 493) Borderline Isolated Systolic Hypertension (n 1241) Normotension (n 6656) Age, y * * * Sex Men 1924 (49) 179 (36) 535 (43) 2425 (36) Women 2030 (51)* 314 (64) 706 (67)* 4231 (64) Race/ethnicity White 3151 (80) 401 (81) 1079 (87) 5909 (89) Black 770 (19)* 88 (17)* 149 (12) 683 (10) Other 33 (1) 4 (2) 13 (1) 64 (1) Diabetes mellitus Yes 157 (40)* 51 (10)* 74 (6)* 110 (2) Data unavailable 866 (22) 49 (10)* 183 (15)* 1550 (23) No 2931 (38) 393 (80) 984 (79) 4996 (75) Smoking status Current 633 (16)* 32 (6)* 161 (13)* 1755 (26) Former 1211 (31) 136 (28)* 402 (32) 1780 (27) Never 2110 (63) 325 (66) 678 (55) 3121 (47) Education 12 years 1833 (46) 172 (35) 530 (43) 4430 (67) 12 years 2121 (54)* 321 (65)* 711 (57)* 2226 (33) Mean body mass index, kg/m * * * Alcohol Use Frequent 597 (15) 61 (12)* 174 (14)* 754 (11) Infrequent 1601 (40)* 128 (26)* 425 (34)* 3445 (52) None 1756 (45) 304 (62) 642 (52) 2457 (37) Mean cholesterol, mg/dl * * * Values are frequency (percentage) for categorical variables and mean SD for continuous variables. *P value 0.05 using chi-square method or ANOVA. used by previous clinical trials evaluating the effect of treated and untreated hypertension on cardiovascular diseases The data regarding diabetic status were unavailable for a large proportion of participants. The exact relationship between this category of diabetes and stroke is undefined and probably not comparable to participants either with or without documented diabetes mellitus. Therefore, we entered the variable of diabetes mellitus as absent, present, or unknown. A second logistic regression analysis was performed without including serum cholesterol levels in the model. This analysis was performed because serum cholesterol levels may be associated with ischemic stroke but not with intracerebral hemorrhage. 19 Furthermore, an inverse association has been suggested between serum cholesterol levels and intracerebral hemorrhage. 20 Because the exclusion of serum cholesterol levels from the model did not affect the results, the results of the analysis including serum cholesterol levels are presented. All the variables were entered in the model simultaneously to adjust for the potential confounding effect of each variable. A separate Cox proportional hazards analysis was performed to evaluate the effect of the following variables: age, sex, absolute measurement value of systolic and diastolic blood pressure, diabetes mellitus, smoking, serum cholesterol, body mass index, and use of antihypertensive medication on risk of stroke in participants with ISH or BISH. A subset analysis was performed in patients with diastolic hypertension to determine the effect of systolic blood pressure on the risk of stroke compared with normotensive persons. The multivariate-adjusted risk of stroke was analyzed for different levels of systolic blood pressure ( 120, 121 to 150, 151 to 180, and 180 mm Hg). A probability value of 0.05 was considered significant. All analyses were performed with the use of SPSS. Results A total of persons aged 25 to 74 years underwent an interview and examination during the NHANES I baseline survey. A total of 1697 persons were lost to follow-up. Another 366 participants were excluded from the present analysis because of history of stroke or intracerebral hemorrhage (n 299) or unavailability of blood pressure readings (n 67). Those who died from causes other than stroke (n 2738) were censored at the time of death and included in the analysis. Among the total participants included in the analysis (n ), hypertension was categorized as ISH (n 493), BISH (n 1241), and diastolic hypertension (n 3954). Normotension was observed in 6656 persons. During the 20-year follow-up period, stroke events occurred in 825 participants (7%). The rates of ischemic stroke and intracerebral hemorrhage were 745 (6%) and 198 (2%), respectively (118 participants had experienced both types of stroke events). Baseline characteristics of the participants according to blood pressure status are provided in Table 1. Participants with normotension were more likely to be younger and to have attained higher levels of education ( 12

4 2784 Stroke December 2002 TABLE 2. Age-Adjusted and Multivariate-Adjusted Relative Risks of Stroke, Ischemic Stroke, and Intracerebral Hemorrhage Participants Sample Size No. of Strokes Stroke Rate per 100 Age-Adjusted RR (95% CI) Multivariate-Adjusted RR (95% CI) All strokes Normotension Reference Reference Diastolic hypertension ( ) 1.9 ( ) ISH ( ) 2.7 ( ) BISH ( ) 1.4 ( ) Ischemic stroke Normotension Reference Reference Diastolic hypertension ( ) 1.9 ( ) ISH ( ) 2.7 ( ) BISH ( ) 1.4 ( ) Intracerebral hemorrhage Normotension Reference Reference Diastolic hypertension ( ) 2.4 ( ) ISH ( ) 3.1 ( ) BISH ( ) 2.1 ( ) Multivariate-adjusted for age, sex, race, body mass index, smoking, alcohol use, cholesterol level, education, history of myocardial infarction, and diabetes mellitus. RR indicates relative risk; ISH, isolated systolic hypertension; BISH, borderline isolated systolic hypertension. years) than those with ISH, BISH, or diastolic hypertension. Moreover, the mean body mass index and mean serum cholesterol levels were lower in the normotensive cohort than in participants with ISH, BISH, or diastolic hypertension. Diabetes mellitus was more frequent in patients with diastolic hypertension. Table 2 provides the stroke rates and age- and multivariate-adjusted RRs of all strokes, ischemic stroke, and intracerebral hemorrhage according to blood pressure status. Participants with ISH, BISH, or diastolic hypertension were 3 to 6 times more likely to have strokes than those with normotension. The stroke rate was 2 times higher in persons with ISH than in those with either BISH or diastolic hypertension. A significantly higher RR for all strokes was observed in participants with ISH (RR, 2.7; 95% CI, 2.0 to 3.4) and BISH (RR, 1.4; 95% CI, 1.1 to 1.8) compared with normotensive persons after adjustment for confounding factors through multivariate analysis. An increased RR for both ischemic stroke and intracerebral hemorrhage was found in persons with ISH, BISH, and diastolic hypertension compared with those with normotension. Table 3 demonstrates the factors that contributed to increased risk for all strokes among participants with ISH or BISH (n 1734). The risk of stroke was higher in persons aged 45 to 64 years and those aged 65 years than in those aged 45 years. Other independent variables associated with risk of stroke were diabetes mellitus (RR, 2.1; 95% CI, 1.4 to 3.3) and systolic blood pressure 180 mm Hg (RR, 2.4; 95% CI, 1.5 to 4.0). Regular or occasional use of antihypertensive medication was not associated with the risk of stroke. In the subset analysis including patients with diastolic hypertension, there was a stepwise increase in the risk for stroke with higher systolic blood pressure. Compared with normotensive patients, the multivariate-adjusted risk of stroke for each category of systolic blood pressure was as follows: 120 mm Hg: RR, 1.0 (95% CI, 0.5 to 2.3); 121 to 150 mm Hg: RR, 1.5 (95% CI, 1.2 to 1.9); 151 to 180 mm Hg: RR, 2.2 (95% CI, 1.8 to 2.7); and 180 mm Hg: RR, 3.1 (95% CI, 2.4 to 4.0). Discussion Our analysis showed that each category of hypertension represented in this study confers an increased risk for stroke, including both ischemic stroke and intracerebral hemorrhage. ISH appeared to pose the highest risk for both types of stroke events. The stroke risk for persons with BISH appears to approximate that for persons with diastolic hypertension. Our analysis also identified characteristics in persons with ISH or BISH that are associated with an increased risk of stroke. ISH as a Risk Factor for Stroke Kannel et al 21 reported prospective data from the Framingham Study relating systolic and diastolic blood pressure, pulse-wave configuration, and patient age to future stroke incidents. Subjects with ISH experienced 2 to 4 times as many strokes as did normotensive persons. Although diastolic blood pressure was related to stroke in subjects with systolic hypertension, the diastolic component added little to the risk assessment in men and was unrelated to the overall incidence of stroke. Systolic pressure seemed to be the more potent contributor of stroke. The Copenhagen City Heart Study, 22 a prospective population survey, evaluated the prevalence of ISH and associated risk of major cardiovascular events. The risk of stroke and myocardial infarction in association with ISH was assessed in 6621 subjects aged 50 years who were not receiving antihypertensive or cardiac medicine and had no history of stroke or myocardial infarction. The prevalence of ISH showed an age-related increase from 3% in 55-year-

5 Qureshi et al ISH and BISH and Stroke Risk 2785 TABLE 3. Predictors of Stroke in Isolated and Borderline Isolated Systolic Hypertension Variables No. of Participants (%) Multivariate-Adjusted RR (95% CI) P Value Age (12) Reference (27) 4.7 ( ) (61) 15.1 (4.7 48) Sex (men) 714 (41) 1.2 ( ) 0.2 Race White 1480 (85) Reference Black 237 (14) 1.2 ( ) 0.4 Other 17 (1) Smoking Current 193 (11) 0.9 ( ) 0.8 Former 538 (31) 1.3 ( ) 0.08 Diabetes mellitus Present 125 (7) 2.1 ( ) 0.01 Unknown 232 (13) Antihypertensive medication use Regular 272 (16) 1.3 ( ) 0.2 Occasional 32 (2) 1.9 ( ) 0.1 Unknown 234 (13) Serum cholesterol ( 200 mg/dl) 1340 (77) 1.2 ( ) 0.3 Body mass index ( 30 kg/m 2 ) 305 (18) 1.2 ( ) 0.3 Education ( 12 years) 1032 (60) 1.2 ( ) 0.3 Systolic BP (80) Reference (16) 1.3 ( ) (4) 2.4 ( ) Diastolic BP (88) Reference (10) 1.4 ( ) (2) 1.8 ( ) 0.4 RR, relative risk; BP, blood pressure. old subjects to 13% in 72-year-old subjects. The RR of stroke after adjustment for other risk factors was 3.0 (95% CI, 1.6 to 5.3) for women and 2.7 (95% CI, 1.8 to 4.3) for men. This was the highest RR among all hypertensive groups. The population-attributable risk for stroke associated with ISH was estimated as 30%. The risk of death from coronary heart disease, stroke, all cardiovascular disease, and all-cause mortality associated with ISH among the middle-aged population was determined in men and women aged 25 to 64 years without history of myocardial infarction or stroke over a 15-year follow-up period. 23 Coronary heart disease, stroke, cardiovascular disease, and mortality from all causes among men and women aged 45 to 64 years increased with increasing levels of systolic blood pressure. Among women aged 45 to 64 years, ISH increased the RR of these fatal events. Among men aged 45 to 64 years, only deaths related to coronary heart disease were significantly associated with ISH. Petrovitch et al 24 examined the prevalence of ISH in a population of 8006 Japanese-American men aged 45 to 68 years and compared rates of stroke among those with ISH, isolated diastolic hypertension, combined systolic-diastolic hypertension, and normotension. Men with ISH had the highest rates of stroke, followed by men with systolic-diastolic hypertension. Men with isolated diastolic hypertension had rates only slightly higher than those of men in the normotension group. RR adjusted for other risk factors varied by age group. For men aged 45 to 54 years, RRs of stroke for subjects with ISH, isolated diastolic hypertension, and systolic-diastolic hypertension (compared with normotensive subjects) were 4.8, 1.4, and 4.3, respectively. For men aged 55 to 68 years, the same RRs were 1.2, 1.8, and 1.7. Borderline Isolated Systolic Hypertension In a follow-up analysis of the Framingham Study, Sagie et al 25 reported on 2667 subjects. During 34 years of monitor-

6 2786 Stroke December 2002 ing, cardiovascular disease events occurred in 1010 subjects, congestive heart failure in 228, and death in After adjustment for age, sex, and cardiovascular risk factors, subjects with BISH (according to blood pressure measurements at baseline examination) had an excess risk of cardiovascular disease (hazard ratio, 1.47; 95% CI, 1.24 to 1.74) and death from cardiovascular disease (hazard ratio, 1.57; 95% CI, 1.24 to 2.00) compared with normotensive subjects. They were also at significantly higher risk for coronary artery disease (hazard ratio, 1.44), stroke and transient ischemic attacks (hazard ratio, 1.42), and congestive heart failure (hazard ratio, 1.60). Impact of Antihypertensive Treatment Recent clinical trials demonstrate the importance of treatment of ISH and risk reduction for stroke and other cardiovascular diseases in the elderly. 16,17 Staessen et al 26 performed a quantitative overview of 8 clinical trials to evaluate the risk associated with systolic blood pressure in treated and untreated elderly patients ( 60 years) with ISH. In these trials, participants with ISH were followed up for 3 to 8 years. Various antihypertensive medications were used to treat ISH. These included thiazides, calcium channel blockers, a combination of thiazide and triamterene, -blockers, and thiazide in combination with either amiloride or a -blocker. Among 7757 placebo-treated patients, major cardiovascular complications occurred in 835 (10.8%) and death occurred in 734 (9.5%) persons. Among 7936 patients who received pharmacological treatment, major complications occurred in 647 (8.1%) and death occurred in 656 (8.3%) persons. Pharmacological treatment of ISH reduced total mortality by 13%, cardiovascular mortality by 18%, all cardiovascular complications by 26%, stroke by 30%, and coronary events by 33%. We observed that in patients with BISH or ISH, antihypertensive treatment did not affect the risk for stroke. This finding may be secondary to treated hypertensives having had years of uncontrolled hypertension. Giles et al, 27 in an analysis of the NHANES I cohort, observed that among persons with a blood pressure 140/ 90 mm Hg, persons who were receiving medication had a mean blood pressure of 164/94 mm Hg, while persons who reported not taking medication had a mean blood pressure of 152/92 mm Hg. The lack of beneficial effect of antihypertensive medication is probably attributable to the presence of more severe hypertension in treated patients. Stroke Types and Subtypes and ISH We observed that the risk of either ischemic stroke or intracerebral hemorrhage is higher in persons with ISH and BISH. In a subgroup analysis in the Systolic Hypertension in the Elderly Program (SHEP), Perry et al 28 evaluated the incidence of stroke types and subtypes in 4736 men and women aged 60 years with ISH from 16 clinical centers in the United States. Participants were randomly assigned to receive treatment with either chlorthalidone (12 mg daily), chlorthalidone (same dose) with atenolol (25 mg daily) or reserpine (0.05 mg daily), or a placebo. They were followed for an average period of 4.5 years. A total of 85 and 132 participants in the active treatment and placebo groups, respectively, had ischemic stroke; 9 and 19 participants, respectively, had hemorrhagic strokes. A significant reduction was observed in the risk for ischemic and hemorrhagic stroke in the active treatment group. No significant difference was observed in the risk for stroke of unknown type. Among patients with ischemic stroke, a significant reduction was observed in the RR for ischemic strokes classified as lacunar and undetermined. The RR was not significantly different for embolic and atherosclerotic ischemic stroke. ISH appeared to have a stronger association with both ischemic stroke and intracerebral hemorrhage compared with BISH and diastolic hypertension (Table 2). No clear evidence exists to support a differential effect of ISH and diastolic hypertension in predisposing to ischemic or hemorrhagic stroke. Davis et al 29 determined the risk factors for stroke and stroke subtype in the SHEP trial. In the multivariate analysis, higher systolic blood pressure was associated with an increased risk for stroke and ischemic stroke. No definite relationship could be demonstrated between systolic blood pressure and hemorrhagic stroke, atherosclerotic ischemic stroke, lacunar ischemic stroke, or embolic stroke. However, the analysis was limited because of the small number of patients in each of the outcome categories. A report of a combined analysis of 13 cohorts from eastern Asia reported the effect of baseline diastolic pressure on risk of ischemic and hemorrhagic stroke in participants with person-years of observation. 19 Logistic regression analyses demonstrated a somewhat stronger association between diastolic blood pressure and hemorrhagic stroke in comparison with ischemic stroke. Persons With ISH and BISH at Risk for Stroke We found a higher risk of stroke among participants with ISH or BISH aged 45 years. Other persons at higher risk included diabetics, and those with systolic blood pressures 180 mm Hg. Previous studies have recognized the prognostic importance of age and diabetes mellitus for determining the risk of stroke among patients with ISH. Davis et al 29 performed proportional hazards analyses of data from the SHEP to determine risk factors for stroke and stroke type in persons with ISH. During an average follow-up of 4.5 years, 384 strokes or transient ischemic attacks and 262 strokes (including 217 ischemic, 66 lacunar, 26 atherosclerotic, and 25 embolic strokes) were documented. The authors concluded that in older persons with ISH, history of diabetes and smoking are important risk factors for lacunar stroke, whereas carotid bruit and age are important risk factors for atherosclerotic and embolic stroke, respectively. In the SHEP pilot project, Siegel et al 30 examined the effect of known cardiovascular risk factors in younger persons to see whether they were applicable in an elderly population. They prospectively followed up 551 men and women aged 60 years and who had pretreatment systolic blood pressures 160 mm Hg and diastolic blood pressures 90 mm Hg. After adjustment for confounding variables, age, level of education, history of cardiovascular event, and smoking remained significant predictors of a first-time cardiovascular event. We did not find a relationship between diastolic blood pressure and risk of stroke. In a subgroup analysis of the 4736 participants in

7 Qureshi et al ISH and BISH and Stroke Risk 2787 SHEP, Somes et al 31 found, for persons with ISH, that a decrease of 5 mm Hg in diastolic BP increased the risk for stroke (RR, 1.14), coronary heart disease (RR, 1.08), and cardiovascular disease (RR, 1.11). Issues Related to Data Interpretation We used the blood pressure recording from baseline evaluation to define various forms of hypertension. Blood pressure is not static but rather a continuous variable that changes from minute to minute. 32 Therefore, casual blood pressure readings represent a minute part of the entire 24-hour circadian blood pressure pattern. In addition, some patients may manifest a transient stress response when blood pressure is measured in the presence of a medical professional (white coat hypertension). Perloff et al 33 evaluated 1076 persons with both office and ambulatory blood pressure measurements. The ambulatory measurements were obtained with a semiautomatic patient-activated portable device (10 to 40 measurements per patient over 1 to 2 days). The ambulatory blood pressure measurements were lower than office measurements in 78% of the patients. The effect of this overestimation by office blood pressure measurement was most prominent in women and persons with borderline hypertension. The relationship between the measurements generated by these 2 methods correlated in a linear manner. Our use of a single blood pressure measurement to define various forms of hypertension may have led to inclusion of nonhypertensive patients in the BISH category. Because of the presence of normotensive persons, the actual risk of stroke in persons with BISH may be higher than that determined in our study. We used International Classification of Diseases, Ninth Revision (ICD-9) codes from discharge abstracts and death certificates to identify incident cases of stroke and stroke subtypes. Broderick et al 34 determined the accuracy and yield of ICD-9-CM codes for cases of stroke and transient ischemic attack in a population-based study. The ICD-9 diagnoses were compared with the diagnoses made by the study neurologist after review of clinical and radiographic information for each potential case. When primary discharge diagnoses of ICD-9-CM codes 430 to 436 were used, the true positive rate was 83% and the yield of cases of stroke and transient ischemic attack was 84%. The validity of death certificate diagnosis of stroke and its type as the underlying cause of death was investigated in a sample of in-hospital deaths of possible stroke cases from the Minnesota Heart Survey. 35 Relative to a standardized physician diagnosis, positive predictive values for the death certificate diagnosis were 100% for all types of stroke, 82% for intracranial hemorrhage, and 97% for nonhemorrhagic stroke. On the basis of results of previous population-based studies, we think that hospital discharge or death certificate diagnoses are sufficiently accurate to justify their use in epidemiologic studies. Probably most important, the validity of ICD-9 diagnoses does not differ by strata defined by blood pressure. The follow-up rates differed by age, with the lowest tracing rate observed in participants aged 45 years. Because the majority of strokes occur among older adults, participants lost to follow-up could not have substantially biased the results presented in this report. Conclusions We observed that BISH is a category of hypertension that is associated with an increased risk of stroke, ischemic stroke, and intracerebral hemorrhage, which is similar to that associated with ISH and diastolic hypertension. The increased risk of stroke was also observed in the younger group of participants (aged 45 to 64 years) who had systolic hypertension. Future clinical trials should evaluate the effect of antihypertensive treatment in younger persons with BISH and ISH. References 1. Levy D. The role of systolic blood pressure in determining risk for cardiovascular disease. J Hypertens Suppl. 1999;17:S15 S Kocemba J, Kawecka-Jaszcz K, Gryglewska B, Grodzicki T. Isolated systolic hypertension: pathophysiology, consequences and therapeutic benefits. J Hum Hypertens. 1998;12: Staessen J, Amery A, Fagard R. Isolated systolic hypertension in the elderly. J Hypertens. 1990;8: Joint National Committee. Hypertension prevalence and the status of awareness, treatment, and control in the United States: final report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee. Hypertension. 1985;7: Joint National Committee. The report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1988;148: Joint National Committee. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153: Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. Hypertension. 1993;22: Curb JD, Borhani NO, Entwisle G, Tung B, Kass E, Schnaper H, Williams W, Berman R. Isolated systolic hypertension in 14 communities. Am J Epidemiol. 1985;121: Wilking SV, Belanger A, Kannel WB, D Agostino RB, Steel K. Determinants of isolated systolic hypertension. JAMA. 1988;260: Cornoni-Huntley J, Barbano HE, Brody JA, Cohen B, Feldman JJ, Kleinman JC, Madans J. National Health and Nutrition Examination I: epidemiologic follow-up survey. Public Health Rep. 1983;98: Madans JH, Kleinman JC, Cox CS, Barbano HE, Feldman JJ, Cohen B, Finucane FF, Cornoni-Huntley J. 10 years after NHANES I: report of initial followup, Public Health Rep. 1986;101: Qureshi AI, Giles WH, Croft JB. Racial differences in the incidence of intracerebral hemorrhage: effects of blood pressure and education. Neurology. 1999;52: Qureshi AI, Giles WH, Croft JB, Bliwise DL. Habitual sleep patterns and risk for stroke and coronary heart disease: a 10-year follow-up from NHANES I. Neurology. 1997;48: Qureshi AI, Giles WH, Croft JB, Stern BJ. Number of pregnancies and risk for stroke and stroke subtypes. Arch Neurol. 1997;54: Cox CS, Mussolino ME, Rothwell ST, Lane MA, Golden CD, Madans JH, Feldman JJ. Plan and operation of the NHANES I Epidemiologic Followup Study, Vital Health Stat ;35: Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265: Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350: Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ. 1986;29: Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet. 1998;352:

8 2788 Stroke December Yano K, Reed DM, MacLean CJ. Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke. 1989;20: Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension: the Framingham Study. Circulation. 1980;61: Nielsen WB, Vestbo J, Jensen GB. Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an unexploited source of cardiovascular prevention: a prospective population-based study. J Hum Hypertens. 1995;9: Antikainen R, Jousilahti P, Tuomilehto J. Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population. J Hypertens. 1998;16: Petrovitch H, Curb JD, Bloom-Marcus E. Isolated systolic hypertension and risk of stroke in Japanese-American men. Stroke. 1995;26: Sagie A, Larson MG, Levy D. The natural history of borderline isolated systolic hypertension. N Engl J Med. 1993;329: Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, Coope J, Ekbom T, Gueyffier F, Liu L, Kerlikowske K, Pocock S, Fagard RH. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355: Giles WH, Kittner SJ, Hebel JR, Losonczy KG, Sherwin RW. Determinants of black-white differences in the risk of cerebral infarction: the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Arch Intern Med. 1995;155: Perry HM Jr, Davis BR, Price TR, Applegate WB, Fields WS, Guralnik JM, Kuller L, Pressel S, Stamler J, Probstfield JL. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 2000;284: Davis BR, Vogt T, Frost PH, Burlando A, Cohen J, Wilson A, Brass LM, Frishman W, Price T, Stamler J, for the Systolic Hypertension in the Elderly Program Cooperative Research Group. Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Stroke. 1998;29: Siegel D, Kuller L, Lazarus NB, Black D, Feigal D, Hughes G, Schoenberger JA, Hulley SB. Predictors of cardiovascular events and mortality in the Systolic Hypertension in the Elderly Program pilot project. Am J Epidemiol. 1987;126: Somes GW, Pahor M, Shorr RI, Cushman WC, Applegate WB. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med. 1999;159: Sorof JM, Portman RJ. Ambulatory blood pressure measurements. Curr Opin Pediatr. 2001;13: Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA. 1983;249: Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, Gebel J, Mills D, Minneci L, Shukla R. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29: Iso H, Jacobs DR, Goldman L. Accuracy of death certificate diagnosis of intracerebral hemorrhage and nonhemorrhagic stroke: the Minnesota Heart Study. Am J Epidemiol. 1990;132:

Overview of the outcome trials in older patients with isolated systolic hypertension

Overview of the outcome trials in older patients with isolated systolic hypertension Journal of Human Hypertension (1999) 13, 859 863 1999 Stockton Press. All rights reserved 0950-9240/99 $15.00 http://www.stockton-press.co.uk/jhh Overview of the outcome trials in older patients with isolated

More information

Antihypertensive Drug Therapy and Survival by Treatment Status in a National Survey

Antihypertensive Drug Therapy and Survival by Treatment Status in a National Survey 1-28 Antihypertensive Drug Therapy and Survival by Treatment Status in a National Survey Richard J. Havlik, Andrea Z. LaCroix, Joel C. Kleinman, Deborah D. Ingram, Tamara Harris, and Joan Cornoni-Huntley

More information

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice (2005) 19, 801 807 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Prognostic significance of blood pressure measured in the office, at home and

More information

University of Groningen. Isolated systolic hypertension Heesen, Willem Frederik

University of Groningen. Isolated systolic hypertension Heesen, Willem Frederik University of Groningen Isolated systolic hypertension Heesen, Willem Frederik IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check

More information

Regular egg consumption does not increase the risk of stroke and cardiovascular diseases

Regular egg consumption does not increase the risk of stroke and cardiovascular diseases Med Sci Monit, 2007; 13(1): CR1-8 PMID: 17179903 WWW.MEDSCIMONIT.COM Clinical Research Received: 2005.07.27 Accepted: 2006.01.05 Published: 2006.12.22 Regular egg consumption does not increase the risk

More information

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial [HYVET] R. Peters

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial [HYVET] R. Peters Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial [HYVET] R. Peters ClinicalTrials.gov: NCT00122811 Backgound The prevalence of dementia rises with increasing

More information

Risk Factors for Ischemic Stroke: Electrocardiographic Findings

Risk Factors for Ischemic Stroke: Electrocardiographic Findings Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead

More information

Hypertension. Hypertension Subtype and Risk of Cardiovascular Disease in Chinese Adults

Hypertension. Hypertension Subtype and Risk of Cardiovascular Disease in Chinese Adults Hypertension Hypertension Subtype and Risk of Cardiovascular Disease in Chinese Adults Tanika N. Kelly, MPH; Dongfeng Gu, MD, PhD; Jing Chen, MD, MSc; Jian-feng Huang, MD; Ji-chun Chen, MD; Xiufang Duan,

More information

Hypertension is an important public health challenge in

Hypertension is an important public health challenge in Scientific Contributions Long-Term Absolute Benefit of Lowering Blood Pressure in Hypertensive Patients According to the JNC VI Risk Stratification Lorraine G. Ogden, Jiang He, Eva Lydick, Paul K. Whelton

More information

The problem of uncontrolled hypertension

The problem of uncontrolled hypertension (2002) 16, S3 S8 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh The problem of uncontrolled hypertension Department of Public Health and Clinical Medicine, Norrlands

More information

Slide notes: References:

Slide notes: References: 1 2 3 Cut-off values for the definition of hypertension are systolic blood pressure (SBP) 135 and/or diastolic blood pressure (DBP) 85 mmhg for home blood pressure monitoring (HBPM) and daytime ambulatory

More information

Large therapeutic studies in elderly patients with hypertension

Large therapeutic studies in elderly patients with hypertension (2002) 16 (Suppl 1), S38 S43 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh Large therapeutic studies in elderly patients with hypertension Centro Clinico Profesional

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright 2001 by the Massachusetts Medical Society VOLUME 345 N OVEMBER 1, 2001 NUMBER 18 IMPACT OF HIGH-NORMAL BLOOD PRESSURE ON THE RISK OF CARDIOVASCULAR DISEASE

More information

Comparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study

Comparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study 80 Comparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study Thomas Truelsen, MB; Ewa Lindenstrtfm, MD; Gudrun Boysen, DMSc Background and Purpose We wished to

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Berry JD, Dyer A, Cai X, et al. Lifetime risks of cardiovascular

More information

YOUNG ADULT MEN AND MIDDLEaged

YOUNG ADULT MEN AND MIDDLEaged BRIEF REPORT Favorable Cardiovascular Profile in Young Women and Long-term of Cardiovascular and All-Cause Mortality Martha L. Daviglus, MD, PhD Jeremiah Stamler, MD Amber Pirzada, MD Lijing L. Yan, PhD,

More information

Hypertension in Adults Across the Age Spectrum

Hypertension in Adults Across the Age Spectrum ORIGINAL CONTRIBUTION Hypertension in Adults Across the Age Spectrum Current Outcomes and Control in the Community Donald M. Lloyd-Jones, MD, ScM Jane C. Evans, DSc Daniel Levy, MD ELDERLY PERSONS ARE

More information

Is Prehypertension a Risk Factor for Cardiovascular Diseases?

Is Prehypertension a Risk Factor for Cardiovascular Diseases? Is Prehypertension a Risk Factor for Cardiovascular Diseases? Adnan I. Qureshi, MD; M. Fareed K. Suri, MD; Jawad F. Kirmani, MD; Afshin A. Divani, PhD; Yousef Mohammad, MD Background and Purpose The Joint

More information

Transient Ischemic Attacks and Risk of Stroke in an Elderly Poor Population

Transient Ischemic Attacks and Risk of Stroke in an Elderly Poor Population Transient Ischemic Attacks and Risk of Stroke in an Elderly Poor Population BY A. M. OSTFELD, M.D., R. B. SHEKELLE, Ph.D., AND H. L. KLAWANS, M.D. Abstract: Transient Ischemic A t tacks and Risk of Stroke

More information

Physical Activity and Stroke Incidence in Women and Men

Physical Activity and Stroke Incidence in Women and Men American Journal of Epidemiology Copyright 1996 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 143, No. 9 Printed In U.S.A Physical Activity and Stroke Incidence

More information

Frequency of Isolated Systolic Hypertension in Elderly Hypertensives

Frequency of Isolated Systolic Hypertension in Elderly Hypertensives ORIGINAL ARTICLE Frequency of Isolated Systolic Hypertension in Elderly Hypertensives HINA HUSSAIN, HUMA HUSSAIN ABSTRACT Aim: To study frequency of isolated systolic hypertension in elderly hypertensive.

More information

Stroke is the third leading cause of death in the

Stroke is the third leading cause of death in the Probability of Stroke: A Risk Profile From the Framingham Study Philip A. Wolf, MD; Ralph B. D'Agostino, PhD; Albert J. Belanger, MA; and William B. Kannel, MD A health risk appraisal function has been

More information

ORIGINAL INVESTIGATION. Risk Factors for Congestive Heart Failure in US Men and Women

ORIGINAL INVESTIGATION. Risk Factors for Congestive Heart Failure in US Men and Women ORIGINAL INVESTIGATION Risk Factors for Congestive Heart Failure in US Men and Women NHANES I Epidemiologic Follow-up Study Jiang He, MD, PhD; Lorraine G. Ogden, MS; Lydia A. Bazzano, PhD; Suma Vupputuri,

More information

Novel Approach to Examining First Cardiovascular Events After Hypertension Onset

Novel Approach to Examining First Cardiovascular Events After Hypertension Onset Novel Approach to Examining First Cardiovascular Events After Hypertension Onset Donald M. Lloyd-Jones, Eric P. Leip, Martin G. Larson, Ramachandran S. Vasan, Daniel Levy Abstract Hypertension confers

More information

Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex

Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Prevention and Rehabilitation Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Nathan D. Wong, PhD, a Gaurav Thakral, BS, a Stanley S. Franklin,

More information

Systolic blood pressure (SBP) increases with age until the

Systolic blood pressure (SBP) increases with age until the Systolic and Diastolic Blood Pressure Lowering as Determinants of Cardiovascular Outcome Ji-Guang Wang, Jan A. Staessen, Stanley S. Franklin, Robert Fagard, François Gueyffier Abstract Based on individual

More information

Effect of Treating Isolated Systolic Hypertension on the Risk of Developing Various Types and Subtypes of Stroke

Effect of Treating Isolated Systolic Hypertension on the Risk of Developing Various Types and Subtypes of Stroke ORIGINAL CONTRIBUTION Effect of Treating Isolated Systolic Hypertension on the Risk of Developing Various Types and Subtypes of Stroke The Systolic Hypertension in the Elderly Program (SHEP) H. Mitchell

More information

47 Hypertension in Elderly

47 Hypertension in Elderly 47 Hypertension in Elderly YOU DO NOT HEAL OLD AGE; YOU PROTECT IT; YOU PROMOTE IT; YOU EXTEND IT Sir James Sterling Ross Abstract: The prevalence of hypertension rises with age and the complications secondary

More information

It is accepted by a broad consensus that a blood pressure

It is accepted by a broad consensus that a blood pressure Control of Hypertension and Risk of Stroke Recurrence Gary Friday, MD, MPH; Milton Alter, MD, PhD; Sue-Min Lai, PhD, MS Background and Purpose We investigated whether low blood pressure increases the risk

More information

Blood Pressure Targets: Where are We Now?

Blood Pressure Targets: Where are We Now? Blood Pressure Targets: Where are We Now? Diana Cao, PharmD, BCPS-AQ Cardiology Assistant Professor Department of Clinical & Administrative Sciences California Northstate University College of Pharmacy

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines

More information

Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments

Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments ORIGINAL ARTICLE doi: 10.1111/j.1472-8206.2005.00356.x Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments Jean-Pierre Boissel a *, François

More information

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen

More information

T. Suithichaiyakul Cardiomed Chula

T. Suithichaiyakul Cardiomed Chula T. Suithichaiyakul Cardiomed Chula The cardiovascular (CV) continuum: role of risk factors Endothelial Dysfunction Atherosclerosis and left ventricular hypertrophy Myocardial infarction & stroke Endothelial

More information

Recently, there is growing evidence that arterial

Recently, there is growing evidence that arterial AJH 2004; 17:439 445 Sleep Pulse Pressure and Awake Mean Pressure as Independent Predictors for Stroke in Older Hypertensive Patients Kazuomi Kario, Joji Ishikawa, Kazuo Eguchi, Masato Morinari, Satoshi

More information

Diastolic hypertension, defined as a diastolic blood pressure

Diastolic hypertension, defined as a diastolic blood pressure Hypertension Predictors of New-Onset Diastolic and Systolic Hypertension The Framingham Heart Study Stanley S. Franklin, MD; Jose R. Pio, BS; Nathan D. Wong, PhD; Martin G. Larson, ScD; Eric P. Leip, MS;

More information

ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION*

ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION* Progress in Clinical Medicine 1 ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION* Keishi ABE** Asian Med. J. 44(2): 83 90, 2001 Abstract: J-MUBA was a large-scale clinical

More information

ORIGINAL INVESTIGATION

ORIGINAL INVESTIGATION ORIGINAL INVESTIGATION Influence of Long-term, Low-Dose, Diuretic-Based, Antihypertensive Therapy on Glucose, Lipid, Uric Acid, and Potassium Levels in Older Men and Women With Isolated Systolic Hypertension

More information

Antihypertensive Trial Design ALLHAT

Antihypertensive Trial Design ALLHAT 1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes

More information

Diabetologia 9 Springer-Verlag 1991

Diabetologia 9 Springer-Verlag 1991 Diabetologia (1991) 34:590-594 0012186X91001685 Diabetologia 9 Springer-Verlag 1991 Risk factors for macrovascular disease in mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease

More information

The Greater Cincinnati/Northern Kentucky Stroke Study

The Greater Cincinnati/Northern Kentucky Stroke Study Pathophysiology/Complications O R I G I N A L A R T I C L E Epidemiology of Ischemic Stroke in Patients With Diabetes The Greater Cincinnati/Northern Kentucky Stroke Study BRETT M. KISSELA, MD 1 JANE KHOURY,

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright 2001 by the Massachusetts Medical Society VOLUME 345 A UGUST 16, 2001 NUMBER 7 CHARACTERISTICS OF PATIENTS WITH UNCONTROLLED IN THE UNITED STATES DAVID J.

More information

Other views (commentary on "Antihypertensive therapy: beta-blockers and diuretics")

Other views (commentary on Antihypertensive therapy: beta-blockers and diuretics) BUMC Proceedings 2000;13:131-134 Other views (commentary on "Antihypertensive therapy: beta-blockers and diuretics") r. Messerli has advanced what, on the surface, appears to be a convincing argument that

More information

Stroke is among the leading causes of death and longterm

Stroke is among the leading causes of death and longterm Prospective Study of Anxiety and Incident Stroke Maya J. Lambiase, PhD; Laura D. Kubzansky, PhD; Rebecca C. Thurston, PhD Background and Purpose Higher levels of anxiety are associated with increased risk

More information

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women European Heart Journal (2002) 23, 528 535 doi:10.1053/euhj.2001.2888, available online at http://www.idealibrary.com on Combined effects of systolic blood pressure and serum cholesterol on cardiovascular

More information

ALLHAT Role of Diuretics in the Prevention of Heart Failure - The Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial

ALLHAT Role of Diuretics in the Prevention of Heart Failure - The Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial 1 ALLHAT Role of Diuretics in the Prevention of Heart Failure - The Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial Davis BR, Piller LB, Cutler JA, et al. Circulation 2006.113:2201-2210.

More information

Hypertension is a major risk factor for stroke in developed

Hypertension is a major risk factor for stroke in developed Prediction of Stroke by Self-Measurement of Blood Pressure at Home Versus Casual Screening Blood Pressure Measurement in Relation to the Joint National Committee 7 Classification The Ohasama Study Kei

More information

Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan.

Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Manabu Izumi, Kazuo Suzuki, Tetsuya Sakamoto and Masato Hayashi Jichi Medical University

More information

CONSIDERABLE STRIDES HAVE

CONSIDERABLE STRIDES HAVE ORIGINAL INVESTIGATION Comparison of Risk Factors for Cardiovascular Mortality in Black and White Adults Mercedes R. Carnethon, PhD; Elizabeth B. Lynch, PhD; Alan R. Dyer, PhD; Donald M. Lloyd-Jones, MD,

More information

The Antihypertensive and Lipid-Lowering Treatment to

The Antihypertensive and Lipid-Lowering Treatment to Scientific Contributions Diuretic Versus -Blocker as First-Step Antihypertensive Therapy Final Results From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) ALLHAT

More information

Effect of Medicine Adherence on the Occurrence of Cerebrovascular Disorders in Diabetes Mellitus Patients

Effect of Medicine Adherence on the Occurrence of Cerebrovascular Disorders in Diabetes Mellitus Patients Epidemiology and Health Epidemiology and Health Volume: 33, Article ID: e2011001, 6 pages DOI 10.4178/epih/e2011001 ORIGINAL ARTICLE Effect of Medicine Adherence on the Occurrence of Cerebrovascular Disorders

More information

High-Normal Blood Pressure Progression to Hypertension in the Framingham Heart Study

High-Normal Blood Pressure Progression to Hypertension in the Framingham Heart Study 22 High- Blood Pressure Progression to Hypertension in the Framingham Heart Study Mark Leitschuh, L. Adrienne Cupples, William Kannel, David Gagnon, and Aram Chobanian This study sought to determine if

More information

TEN-YEAR ABSOLUTE RISK ESTImates

TEN-YEAR ABSOLUTE RISK ESTImates ORIGINAL CONTRIBUTION CLINICIAN S CORNER Lifetime Risk and Years Lived Free of Total Cardiovascular Disease Scan for Author Video Interview John T. Wilkins, MD, MS Hongyan Ning, MD, MS Jarett Berry, MD,

More information

김광일 서울대학교의과대학내과학교실 분당서울대학교병원내과

김광일 서울대학교의과대학내과학교실 분당서울대학교병원내과 치매예방을위한만성질환관리전략 김광일 서울대학교의과대학내과학교실 분당서울대학교병원내과 A sharp rise in the death rate from Alzheimer s disease Ivan Casserly & Eric Topol, Lancet 2004 Potential for primary prevention of Alzheimer s disease Alzheimer

More information

ORIGINAL INVESTIGATION. Prognosis of Isolated Systolic and Isolated Diastolic Hypertension as Assessed by Self-Measurement of Blood Pressure at Home

ORIGINAL INVESTIGATION. Prognosis of Isolated Systolic and Isolated Diastolic Hypertension as Assessed by Self-Measurement of Blood Pressure at Home Prognosis of Isolated Systolic and Isolated Diastolic Hypertension as Assessed by Self-Measurement of Blood Pressure at Home The Ohasama Study ORIGINAL INVESTIGATION Atsushi Hozawa, MD; Takayoshi Ohkubo,

More information

ALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic

ALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic 1 U.S. Department of Health and Human Services National Institutes of Health Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker

More information

High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension

High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension (2005) 19, 491 496 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE High-dose monotherapy vs low-dose combination therapy of calcium channel blockers

More information

Raised blood pressure is an important risk factor for

Raised blood pressure is an important risk factor for Modest Salt Reduction Lowers Blood Pressure in Isolated Systolic Hypertension and Combined Hypertension Feng J. He, Nirmala D. Markandu, Graham A. MacGregor Abstract Many randomized trials have shown that

More information

Patients with isolated systolic hypertension (ISH)

Patients with isolated systolic hypertension (ISH) AJH 2001; 14:798 803 Association of Increased Pulse Pressure With the Development of Heart Failure in SHEP John B. Kostis, Janet Lawrence-Nelson, Rajiv Ranjan, Alan C. Wilson, William J. Kostis, and Clifton

More information

The Effect of Isosorbide Dinitrate Intravenous Injection on the Hemodynamics and Arterial Stiffness of Patients with Isolated Systolic Hypertension

The Effect of Isosorbide Dinitrate Intravenous Injection on the Hemodynamics and Arterial Stiffness of Patients with Isolated Systolic Hypertension Original ORIGINAL Article ARTICLE Korean Circulation J 2007;37:359-364 ISSN 1738-5520 c 2007, The Korean Society of Circulation The Effect of Isosorbide Dinitrate Intravenous Injection on the Hemodynamics

More information

Journal of Hypertension 2004, 22: a Hypertension and Cardiovascular Rehabilitation Unit, Catholic University of

Journal of Hypertension 2004, 22: a Hypertension and Cardiovascular Rehabilitation Unit, Catholic University of Original article 81 Relationship between ambulatory blood pressure and followup clinic blood pressure in elderly patients with systolic hypertension Robert H. Fagard a, Jan A. Staessen a, Lutgarde Thijs

More information

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS? HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL

More information

ORIGINAL INVESTIGATION. Elevated Midlife Blood Pressure Increases Stroke Risk in Elderly Persons

ORIGINAL INVESTIGATION. Elevated Midlife Blood Pressure Increases Stroke Risk in Elderly Persons Elevated Midlife Blood Increases Stroke Risk in Elderly Persons The Framingham Study ORIGINAL INVESTIGATION Sudha Seshadri, MD; Philip A. Wolf, MD; Alexa Beiser, PhD; Ramachandran S. Vasan, MD; Peter W.

More information

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized

More information

Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease

Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Cronicon OPEN ACCESS EC NEUROLOGY Research Article Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Jin Ok Kim, Hyung-IL Kim, Jae Guk Kim, Hanna Choi, Sung-Yeon

More information

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 Donald J. DiPette MD FACP Special Assistant to the Provost for Health Affairs Distinguished Health Sciences Professor University of South Carolina University

More information

Lydia A Bazzano, Jiang He, Lorraine G Ogden, Catherine M Loria, Suma Vupputuri, Leann Myers, and Paul K Whelton

Lydia A Bazzano, Jiang He, Lorraine G Ogden, Catherine M Loria, Suma Vupputuri, Leann Myers, and Paul K Whelton Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study 1 3 Lydia A Bazzano, Jiang He, Lorraine

More information

Hypertension in the Elderly

Hypertension in the Elderly CardioCase of the Month Hypertension in the Elderly By Luc Trudeau, MD CardioCase Presentation Case Facts Georges is a 63-year-old retired civil servant. He stopped smoking 10 years ago. He denies experiencing

More information

Alcohol Consumption and Mortality Risks in the U.S. Brian Rostron, Ph.D. Savet Hong, MPH

Alcohol Consumption and Mortality Risks in the U.S. Brian Rostron, Ph.D. Savet Hong, MPH Alcohol Consumption and Mortality Risks in the U.S. Brian Rostron, Ph.D. Savet Hong, MPH 1 ABSTRACT This study presents relative mortality risks by alcohol consumption level for the U.S. population, using

More information

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between

More information

Multiple clinical and observational studies in the elderly

Multiple clinical and observational studies in the elderly Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US Hypertensives Analysis Based on National Health and Nutrition Examination Survey (NHANES) III Stanley S. Franklin, Milagros

More information

Egyptian Hypertension Guidelines

Egyptian Hypertension Guidelines Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich

More information

Using the New Hypertension Guidelines

Using the New Hypertension Guidelines Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in

More information

MORBIDITY AND MORTALity

MORBIDITY AND MORTALity ORIGINAL CONTRIBUTION Smoking and Atherosclerotic Cardiovascular Disease in Men With Low Levels of Serum Cholesterol The Korea Medical Insurance Corporation Study Sun Ha Jee, PhD, MHS Il Suh, MD, PhD Il

More information

Adult Hypertension Is Associated With Blood Pressure Variability in Childhood in Blacks and Whites: The Bogalusa Heart Study

Adult Hypertension Is Associated With Blood Pressure Variability in Childhood in Blacks and Whites: The Bogalusa Heart Study nature publishing group original contributions Adult Hypertension Is Associated With Blood Pressure Variability in Childhood in Blacks and Whites: The Bogalusa Heart Study Wei Chen 1,2, Sathanur R. Srinivasan

More information

Hypertension. Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute

Hypertension. Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute Hypertension Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute Hypertension 2017 Classification BP Category Systolic Diastolic Normal 120 and 80 Elevated

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

Managing HTN in the Elderly: How Low to Go

Managing HTN in the Elderly: How Low to Go Managing HTN in the Elderly: How Low to Go Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of the Women s Cardiovascular

More information

Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital

Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8 Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital Objectives Review the Eighth Joint National Committee (JNC

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bucholz EM, Butala NM, Ma S, Normand S-LT, Krumholz HM. Life

More information

High Density Lipoprotein Cholesterol and Mortality

High Density Lipoprotein Cholesterol and Mortality High Density Lipoprotein Cholesterol and Mortality The Framingham Heart Study Peter W.F. Wilson, Robert D. Abbott, and William P. Castelli In 12 years of follow-up for 2748 Framingham Heart Study participants

More information

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose. JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES Tiffany Dickey, PharmD Assistant Professor, UAMS COP Clinical Pharmacy Specialist, Mercy Hospital Northwest AR DISCLOSURE I

More information

Hypertension in the Elderly. John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care

Hypertension in the Elderly. John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care Hypertension in the Elderly John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care Learning Objectives Review evidence for treatment of hypertension in elderly Consider

More information

University of Padova, Padua, Italy, and HARVEST Study Group, Italy

University of Padova, Padua, Italy, and HARVEST Study Group, Italy University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini

More information

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of

More information

Blood pressure (BP) is an established major risk factor for

Blood pressure (BP) is an established major risk factor for Pulse Pressure Compared With Other Blood Pressure Indexes in the Prediction of 25-Year Cardiovascular and All-Cause Mortality Rates The Chicago Heart Association Detection Project in Industry Study Katsuyuki

More information

Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease?

Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease? Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease? The Framingham Heart Study Stanley S. Franklin, MD; Shehzad A. Khan, BS; Nathan D. Wong, PhD; Martin G. Larson, ScD; Daniel Levy,

More information

How well do office and exercise blood pressures predict sustained hypertension? A Dundee Step Test Study

How well do office and exercise blood pressures predict sustained hypertension? A Dundee Step Test Study (2000) 14, 429 433 2000 Macmillan Publishers Ltd All rights reserved 0950-9240/00 $15.00 www.nature.com/jhh ORIGINAL ARTICLE How well do office and exercise blood pressures predict sustained hypertension?

More information

Prevalence of Comorbidities and Their Influence on Blood Pressure Goal Attainment in Geriatric Patients

Prevalence of Comorbidities and Their Influence on Blood Pressure Goal Attainment in Geriatric Patients Original Paper Prevalence of Comorbidities and Their Influence on Blood Pressure Goal Attainment in Geriatric Patients CME Credit 1 www.lejacq.com/cme John D. Bisognano, MD, PhD; 1 Kevin A. Townsend, MS,

More information

Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease

Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease (2002) 16, 837 841 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Low fractional diastolic pressure in the ascending aorta increased the risk

More information

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

The Whitehall II study originally comprised 10,308 (3413 women) individuals who, at

The Whitehall II study originally comprised 10,308 (3413 women) individuals who, at Supplementary notes on Methods The study originally comprised 10,308 (3413 women) individuals who, at recruitment in 1985/8, were London-based government employees (civil servants) aged 35 to 55 years.

More information

Serum Uric Acid and Cardiovascular Mortality

Serum Uric Acid and Cardiovascular Mortality ORIGINAL CONTRIBUTION Acid and Cardiovascular Mortality The NHANES I Epidemiologic Follow-up Study, 1971-199 Jing Fang, MD Michael H. Alderman, MD Context Although many epidemiological studies have suggested

More information

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary 2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth

More information

Blood Pressure Targets in Diabetes

Blood Pressure Targets in Diabetes Stockholm, 29 th August 2010 ESC Meeting Blood Pressure Targets in Diabetes Peter M Nilsson, MD, PhD Department of Clinical Sciences University Hospital, Malmö Sweden Studies on BP in DM2 ADVANCE RCT (Lancet

More information

Dysglycaemia and Hypertension. Dr E M Manuthu Physician Kitale

Dysglycaemia and Hypertension. Dr E M Manuthu Physician Kitale Dysglycaemia and Hypertension Dr E M Manuthu Physician Kitale None Disclosures DM is MI equivalent MR FIT Objective was to assess predictors of CVD mortality among men with and without diabetes and

More information